Contents: Research LetterNonresearch Payments by Industry to Obstetrics and Gynecology Fellowship DirectorsPalmere, Laura MD; Guido, Joseph MS, CHP; Schultz, Claire MD, MPH; Curtin, John MD; Muffly, Tyler M. MDAuthor Information Sisters of Charity Leavenworth Health and Female Pelvic Medicine and Reconstructive Surgery, Denver Health and Hospital Authority, Denver, Colorado. Corresponding author: Laura Palmere, MD, Sisters of Charity Leavenworth, Saint Joseph Hospital, Graduate Medical Education Obstetrics and Gynecology Department, Denver, CO; email: [email protected]. Financial Disclosure The authors did not report any potential conflicts of interest. This project was conducted without financial support from reportable sources. No funding was received from any of the following institutions: National Institutes of Health, Welcome Trust, or the Howard Hughes Medical Institute. Presented at Pelvic Floor Disorders Week 2021, American Urogynecologic Society, October 12–15, 2021, Phoenix, Arizona. Each author has confirmed compliance with the journal's requirements for authorship. Peer reviews and author correspondence are available at https://links.lww.com/AOG/C491. Obstetrics & Gynecology: December 2021 - Volume 138 - Issue 6 - p 894-896 doi: 10.1097/AOG.0000000000004602 Buy Metrics In Brief More than 90% of all obstetrics and gynecology fellowship directors received at least one nonresearch payment from a drug or device manufacturer between 2013 and 2020. © 2021 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.